NAS in Rural America: Supporting both patients and providers leads to better health outcomes

Posted by Andrew Meyer, MD on Jun 10, 2019 1:11:09 PM

ProgenyHealth is committed to helping providers everywhere with one of the most devastating aspects of the opioid crisis: neonatal abstinence syndrome (NAS). With our newly updated Best Practices for Management of Infants with NAS, our clinical team has addressed major issues affecting these babies and their families. 

From 2004-2013, the incidence of NAS and maternal opioid use in the United States increased disproportionately in rural counties from 12.9% in 2003/2004 to 21.2% in 2012/20131.

Read More

Topics: neonatal abstinence syndrome, social determinants of health

Taking-on the opioid crisis, two affected lives at a time: Embracing the mother-infant dyad

Posted by Madeline Szabo on May 15, 2019 4:04:00 PM

ProgenyHealth’s team of neonatologists, pediatric nurses, and social workers have managed over 60,000 NICU cases to-date as part of our neonatal medical management service offering. Infants born with neonatal abstinence syndrome (NAS) – symptoms related to opioid exposure in the womb – represent a complex and growing segment of this population. Tackling their unique challenges requires a specialized approach that supports the needs of both the mother and the baby. 

Read More

Topics: neonatal abstinence syndrome, social determinants of health

Managing Infants with NAS: How We Develop Our Best Practices

Posted by Andrew Meyer, MD on Apr 30, 2019 8:39:12 AM

In our recently updated Best Practices for Management of Infants with Neonatal Abstinence Syndrome (NAS), ProgenyHealth addressed major issues affecting these babies and their families. This new document was researched and developed by the clinical team at ProgenyHealth, which includes neonatologists and pediatricians. The contents were then reviewed and approved by our Medical Advisory Board, a committee of practicing neonatologists from many regions across the U.S., to assure both scientific accuracy and consistency with current clinical practice patterns.

Read More

Topics: neonatal abstinence syndrome, NICU population health, NICU best practices, opioid crisis

Keeping Current with Best Practices for the Treatment of Infants with NAS

Posted by Andrew Meyer, MD on Feb 4, 2019 9:56:00 AM

With our updated Best Practices for Management of Infants with Neonatal Abstinence Syndrome (NAS), ProgenyHealth addresses some of the newest treatment methods, medication doses, transition of care needs, and long-term concerns for these infants.

Neonatal drug withdrawal can occur when newborn infants are exposed to medications or addictive substances in-utero or can occur following prolonged postnatal exposure.

Read More

Topics: Blog, nas, neonatal abstinence syndrome

NAS Awareness Month Brings the Entirety of the Opioid Epidemic Into Focus

Posted by Andrew Meyer, MD on Oct 25, 2018 2:08:39 PM

October marks Neonatal Abstinence Syndrome (NAS) Awareness Month. NAS is the result of the sudden discontinuation of fetal exposure of a substance, typically an opiate such as methadone, heroin, or prescription opiates. It can give afflicted newborns a constellation of symptoms such as: vomiting, loose stools, high-pitched crying, irritability, inconsolability, tremors, sweating, sneezing, poor feeding, or even seizures.

Because of the opioid epidemic in the United States, the incidence of NAS has skyrocketed over the past decade. For the NICU physicians and nurses that care for such unfortunate infants on a regular basis, following best practices for NAS care is crucial.

Read More

Topics: Blog, neonatal abstinence syndrome